Sephoris Pharmaceuticals LLC Report issue

For profit Phase 2
Founded: Jamul CA United States (2010)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2018
NCT03332524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Sephoris Pharmaceuticals LLC

Active Ingredients

Drugs in Phase 2 Trials (2)

chlorpheniramine (1 trial)

ibuprofen (motrin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sunburn (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2